Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

A chemogenetic approach to recovering breathing after opioid-induced respiratory depression

FY 2020-21

Summary
The use of both prescription and non-prescription opioids has led to over 16 000 deaths in Canada over the past 4 years. When opioid overdose occurs, there is a decrease in respiratory rate and potentially total respiratory failure. Currently, Naloxone is effectively used to counteract opioid overdoses but, in recovering breathing, the pain-relieving effects of the opioid is also lost. The pre-Bötzinger complex is known to be a crucial area within the brain for inducing respiration. We believe that selectively activating cells in this region of the brain will allow for recovery of breathing without impacting the pain-relieving effects of opioid treatment. Through viral vectors, we are able to introduce designer receptors into the pre-Bötzinger complex that are not responsive to any naturally occurring substances in the body. After these receptors are incorporated into the cells, we can inject clozapine-N-oxide (CNO) which is known to bind exclusively to these receptors. In theory, only the cells containing the designer receptors will be activated by the injected CNO. Since we only insert these receptors into the pre-Bötzinger complex, CNO injection should cause an increase in respiration. If the system works as we expect, the decrease in breathing caused by opioids can be recovered through subsequent receptor activation with CNO. Ultimately, the goal of this study is to determine whether the pre-Bötzinger complex is an available target for more selective interventions for the recovery of breathing after opioid treatment. Since opioids are crucial in the treatment of pain, there is a need for recovery from respiratory depression without diminishing pain-relief.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449521
Name
Parzei Natalka
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A chemogenetic approach to recovering breathing after opioid-induced respiratory depression
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chemogenetics; Dreadds; Opioids; Pharmacology; Pre-Bötzinger Complex; Respiration; Respiratory Depression
Abstract
The use of both prescription and non-prescription opioids has led to over 16 000 deaths in Canada over the past 4 years. When opioid overdose occurs, there is a decrease in respiratory rate and potentially total respiratory failure. Currently, Naloxone is effectively used to counteract opioid overdoses but, in recovering breathing, the pain-relieving effects of the opioid is also lost. The pre-Bötzinger complex is known to be a crucial area within the brain for inducing respiration. We believe that selectively activating cells in this region of the brain will allow for recovery of breathing without impacting the pain-relieving effects of opioid treatment. Through viral vectors, we are able to introduce designer receptors into the pre-Bötzinger complex that are not responsive to any naturally occurring substances in the body. After these receptors are incorporated into the cells, we can inject clozapine-N-oxide (CNO) which is known to bind exclusively to these receptors. In theory, only the cells containing the designer receptors will be activated by the injected CNO. Since we only insert these receptors into the pre-Bötzinger complex, CNO injection should cause an increase in respiration. If the system works as we expect, the decrease in breathing caused by opioids can be recovered through subsequent receptor activation with CNO. Ultimately, the goal of this study is to determine whether the pre-Bötzinger complex is an available target for more selective interventions for the recovery of breathing after opioid treatment. Since opioids are crucial in the treatment of pain, there is a need for recovery from respiratory depression without diminishing pain-relief.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Parzei, Natalka
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~